At Certara, we accelerate medicines to patients, partnering with life science innovators. Together with our partners, we use biosimulation and technology-enabled services to transform drug discovery and development.
Our integrated and proprietary end-to-end platform with biosimulation, regulatory science, and market access solutions combined with our 900 strong team of scientists and subject matter experts enable informed decision-making, higher R&D productivity, and improved patient outcomes. With our quantitative approach, we address your critical drug discovery and development decisions:
How can dosing be optimized to maximize safety and efficacy?
What is the probability of clinical trial success?
How do we work with regulatory agencies to steer through uncertainty?
What’s the best way to assess and demonstrate maximum value of a new therapy?
Certara works across all therapeutic areas and innovative therapies, including immuno-oncology, rare disease, CNS, respiratory disease, gene therapy, and global health, providing translational solutions from discovery to patient access.
Learn more: https://www.certara.com/company/our-story/
Oct 26, 2021
Posted by Certara
May 24, 2022 - Nov 01, 2022